We are live on ! Find out more
IC

IEQ Capital Portfolio holdings

AUM $21.5B
1-Year Est. Return 75.26%
This Fund
S&P 500
This Quarter Est. Return
+10.06%
1 Year Est. Return
+75.26%
3 Year Est. Return
+200.43%
5 Year Est. Return
+196.91%
10 Year Est. Return
AUM
$10.3B
AUM Growth
+$2.2B
Cap. Flow
+$1.56B
Cap. Flow %
15.06%
Top 10 Hldgs %
37.8%
Holding
1,460
New
303
Increased
604
Reduced
344
Closed
135

Top Sells

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$18.3M
2
TOST icon
Toast
TOST
+$16.6M
3
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$13.6M
4
DIS icon
Walt Disney
DIS
+$7.48M
5
NU icon
Nu Holdings
NU
+$6.71M

Sector Composition

Rank Sector Weight
1 Technology 25.55%
2 Communication Services 18.78%
3 Financials 10.75%
4 Consumer Discretionary 7.42%
5 Healthcare 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGHT icon
1276
8x8 Inc
EGHT
$308M
$85K ﹤0.01%
+31,817
New +$81.7K
KEP icon
1277
Korea Electric Power
KEP
$16.1B
$84.3K ﹤0.01%
12,246
+1,379
+13% +$10.8K
LOGC
1278
DELISTED
ContextLogic
LOGC
$83.8K ﹤0.01%
11,917
RYAM icon
1279
Rayonier Advanced Materials
RYAM
$637M
$82.9K ﹤0.01%
+10,054
New +$84.6K
NXDR
1280
Nextdoor Holdings
NXDR
$959M
$76.6K ﹤0.01%
32,322
-9,646
-23% -$23.9K
CRSR icon
1281
Corsair Gaming
CRSR
$1.15B
$76.5K ﹤0.01%
11,578
-230
-2% -$1.6K
KRNY icon
1282
Kearny Financial
KRNY
$609M
$72.6K ﹤0.01%
+10,250
New +$77.1K
FUBO icon
1283
FuboTV Inc
FUBO
$278M
$72K ﹤0.01%
4,762
CHRS icon
1284
Coherus Oncology
CHRS
$213M
$67.9K ﹤0.01%
+49,183
New +$55.2K
RES icon
1285
RPC Inc
RES
$1.3B
$64.5K ﹤0.01%
+10,860
New +$67.3K
HPP
1286
Hudson Pacific Properties
HPP
$785M
$59.2K ﹤0.01%
2,789
-2,182
-44% -$59.6K
MOBX icon
1287
Mobix Labs
MOBX
$26.3M
$58.9K ﹤0.01%
3,462
+1,462
+73% +$14.9K
TEF
1288
DELISTED
Telefonica
TEF
$57.2K ﹤0.01%
14,218
+2,089
+17% +$9.41K
SAGE
1289
DELISTED
Sage Therapeutics
SAGE
$56.8K ﹤0.01%
+10,468
New +$64K
APPS icon
1290
Digital Turbine
APPS
$1.66B
$55.1K ﹤0.01%
+32,579
New +$72.5K
AVD icon
1291
American Vanguard Corp
AVD
$74.7M
$54.2K ﹤0.01%
+11,706
New +$63.3K
TDAY
1292
USA Today Co
TDAY
$1.18B
$53.9K ﹤0.01%
+10,657
New +$56.6K
OIS icon
1293
Oil States International
OIS
$518M
$53.7K ﹤0.01%
+10,617
New +$52.9K
OPK icon
1294
Opko Health
OPK
$1B
$52.1K ﹤0.01%
+35,419
New +$54.1K
DH icon
1295
Definitive Healthcare
DH
$69.4M
$50.6K ﹤0.01%
+12,307
New +$53.8K
RPTX
1296
DELISTED
Repare Therapeutics
RPTX
$50.3K ﹤0.01%
38,382
HLVX
1297
DELISTED
HilleVax
HLVX
$46.6K ﹤0.01%
22,495
+9,344
+71% +$17.5K
NVRO
1298
DELISTED
NEVRO CORP.
NVRO
$46K ﹤0.01%
+12,369
New +$57.1K
ZNTL icon
1299
Zentalis Pharmaceuticals
ZNTL
$357M
$45.8K ﹤0.01%
+15,115
New +$49.5K
SSP icon
1300
E.W. Scripps
SSP
$278M
$44.8K ﹤0.01%
+20,277
New +$46.8K

Similar funds

IEQ Capital's Q4 2024 Portfolio in Review

As of Q4 2024, IEQ Capital held 1,460 positions worth $10.3B, up 27% from $8.15B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

IEQ Capital deployed $1.56B of net new capital in Q4 2024, opening 303 new positions and adding to 604 existing holdings. Its largest new stake was State Street SPDR US Large Cap Low Volatility Index ETF: 92,605 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was Salesforce, an estimated $18.3M trimmed.

  • IEQ Capital's largest Q4 2024 buy was State Street SPDR US Large Cap Low Volatility Index ETF: 92,605 shares worth $15.3M.
  • IEQ Capital added most to Goldman Sachs in Q4 2024, an estimated $218M increase.
  • IEQ Capital's biggest Q4 2024 reduction was Salesforce, cutting an estimated $18.3M.
  • IEQ Capital fully exited DoubleLine Yield Opportunities Fund in Q4 2024, selling an estimated $5.05M.
  • IEQ Capital's ten largest holdings make up 38% of its $10.3B portfolio in Q4 2024.
  • IEQ Capital opened 303 new positions and closed 135 in Q4 2024.
  • IEQ Capital's portfolio value rose 27% quarter-over-quarter to $10.3B.

Based on IEQ Capital's 13F filing for Q4 2024, filed 3 Feb 2025.